Sunshine Biopharma Inc.
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −2.50 USD per share, beating the −2.50 USD estimate by 0.00%. Revenue for the same period reached 8.09 M USD, despite the estimate of 8.09 M USD. For the next quarter, analysts expect −1.20 USD in earnings per share and 8.70 M USD in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise